305 related articles for article (PubMed ID: 21586326)
1. Production of recombinant peptides as fusions with SUMO.
Satakarni M; Curtis R
Protein Expr Purif; 2011 Aug; 78(2):113-9. PubMed ID: 21586326
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of fermentation media and optimization of expression conditions for the production of EAK(16) peptide as fusions with SUMO.
Satakarni M; Koutinas AA; Webb C; Curtis R
Biotechnol Bioeng; 2009 Feb; 102(3):725-35. PubMed ID: 18973282
[TBL] [Abstract][Full Text] [Related]
3. Expression and purification of an antitumor-analgesic peptide from the venom of Mesobuthus martensii Karsch by small ubiquitin-related modifier fusion in Escherichia coli.
Cao P; Yu J; Lu W; Cai X; Wang Z; Gu Z; Zhang J; Ye T; Wang M
Biotechnol Prog; 2010; 26(5):1240-4. PubMed ID: 20945481
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli.
Sun Z; Xia Z; Bi F; Liu JN
Appl Microbiol Biotechnol; 2008 Mar; 78(3):495-502. PubMed ID: 18189135
[TBL] [Abstract][Full Text] [Related]
5. Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.
Zhang J; Ma L; Zhang SQ
Protein Expr Purif; 2014 Mar; 95():177-81. PubMed ID: 24412409
[TBL] [Abstract][Full Text] [Related]
6. Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner.
Li JF; Zhang J; Song R; Zhang JX; Shen Y; Zhang SQ
Appl Microbiol Biotechnol; 2009 Aug; 84(2):383-8. PubMed ID: 19582446
[TBL] [Abstract][Full Text] [Related]
7. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.
Rao XC; Li S; Hu JC; Jin XL; Hu XM; Huang JJ; Chen ZJ; Zhu JM; Hu FQ
Protein Expr Purif; 2004 Jul; 36(1):11-8. PubMed ID: 15177279
[TBL] [Abstract][Full Text] [Related]
8. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems.
Panavas T; Sanders C; Butt TR
Methods Mol Biol; 2009; 497():303-17. PubMed ID: 19107426
[TBL] [Abstract][Full Text] [Related]
9. Human SUMO fusion systems enhance protein expression and solubility.
Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
[TBL] [Abstract][Full Text] [Related]
10. SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes.
Peroutka Iii RJ; Orcutt SJ; Strickler JE; Butt TR
Methods Mol Biol; 2011; 705():15-30. PubMed ID: 21125378
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
Sun Z; Lu W; Jiang A; Chen J; Tang F; Liu JN
Protein Expr Purif; 2009 Jun; 65(2):238-43. PubMed ID: 19152836
[TBL] [Abstract][Full Text] [Related]
12. Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO technology.
Luan C; Zhang HW; Song DG; Xie YG; Feng J; Wang YZ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3651-58. PubMed ID: 24121930
[TBL] [Abstract][Full Text] [Related]
13. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture.
Hoffmann A; Müller MQ; Gloser M; Sinz A; Rudolph R; Pfeifer S
Protein Expr Purif; 2010 Aug; 72(2):238-43. PubMed ID: 20363332
[TBL] [Abstract][Full Text] [Related]
14. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
[TBL] [Abstract][Full Text] [Related]
15. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.
Marblestone JG; Edavettal SC; Lim Y; Lim P; Zuo X; Butt TR
Protein Sci; 2006 Jan; 15(1):182-9. PubMed ID: 16322573
[TBL] [Abstract][Full Text] [Related]
16. Soluble expression and purification of the recombinant bioactive peptide precursor BPP-1 in Escherichia coli using a cELP-SUMO dual fusion system.
Rao S; Zang X; Yang Z; Gao L; Yin Y; Fang W
Protein Expr Purif; 2016 Feb; 118():113-9. PubMed ID: 26581779
[TBL] [Abstract][Full Text] [Related]
17. SUMO fusion facilitates expression and purification of garlic leaf lectin but modifies some of its properties.
Upadhyay SK; Saurabh S; Rai P; Singh R; Chandrashekar K; Verma PC; Singh PK; Tuli R
J Biotechnol; 2010 Mar; 146(1-2):1-8. PubMed ID: 20100526
[TBL] [Abstract][Full Text] [Related]
18. SUMO as a solubility tag and in vivo cleavage of SUMO fusion proteins with Ulp1.
Kuo D; Nie M; Courey AJ
Methods Mol Biol; 2014; 1177():71-80. PubMed ID: 24943315
[TBL] [Abstract][Full Text] [Related]
19. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology.
Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G
Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523
[TBL] [Abstract][Full Text] [Related]
20. Esterase 2 from Alicyclobacillus acidocaldarius as a reporter and affinity tag for expression and single step purification of polypeptides.
Huang Y; Humenik M; Sprinzl M
Protein Expr Purif; 2007 Jul; 54(1):94-100. PubMed ID: 17399994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
